alisertib
Showing 26 - 36 of 36
Small Cell Lung Cancer Trial in Worldwide (Alisertib, Placebo, Paclitaxel)
Completed
- Small Cell Lung Cancer
- Alisertib
- +2 more
-
Los Angeles, California
- +60 more
Dec 3, 2018
Malignant Digestive System Tumor Trial in United States (Alisertib, Fluorouracil, Laboratory Biomarker Analysis)
Completed
- Malignant Digestive System Neoplasm
- Alisertib
- +4 more
-
New Haven, Connecticut
- +4 more
Oct 5, 2018
Ovarian Carcinoma, Fallopian Tube Cancer, Peritoneal Cancer Trial in United States (Alisertib, Paclitaxel)
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma Trial in Atlanta, Columbus (drug, biological, other)
Terminated
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +10 more
- alisertib
- +2 more
-
Atlanta, Georgia
- +1 more
May 3, 2018
Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma Trial in Mount Holly (Alisertib)
Completed
- Diffuse Large B-cell Lymphoma
- +4 more
- Alisertib
-
Mount Holly, New JerseyHematology Oncology Associates, Virtua Memorial Hospital Burling
Feb 27, 2018
Acute Myelogenous Leukemia, High-Grade Myelodysplastic Syndrome Trial in Morristown (Alisertib)
Completed
- Acute Myelogenous Leukemia
- High-Grade Myelodysplastic Syndrome
- Alisertib
-
Morristown, New JerseyHematology and Oncology Associates of Northern New Jersey
Apr 9, 2018
Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma Trial in Worldwide (Alisertib, Pralatrexate,
Completed
- Relapsed Peripheral T-Cell Lymphoma
- Refractory Peripheral T-Cell Lymphoma
- Alisertib
- +3 more
-
Birmingham, Alabama
- +151 more
Jul 6, 2018
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Philadelphia (Alisertib,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- Alisertib
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Nov 8, 2017
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma Trial in Duarte, Chapel Hills (Alisertib)
Terminated
- Diffuse Large B-cell Lymphoma
- +2 more
- Alisertib
-
Duarte, California
- +1 more
Nov 16, 2017
Malignant Tumors of Digestive Organs, Malignant Tumors of Female Genital Organs, Malignant Tumors of Lip Oral Cavity and Pharynx
Withdrawn
- Malignant Neoplasms of Digestive Organs
- +3 more
- Alisertib
- TAK-228
- (no location specified)
Mar 24, 2017